Chorioallantoic membrane tumor models highlight the effects of cisplatin compounds in oral carcinoma treatment

GraceIntasa-ard, 2019, Nanoparticles characterization using the CAM assay, Enzymes, 46, 129, 10.1016/bs.enz.2019.09.001 Armand, 1995, Chemotherapy in head and neck cancer, Eur. J. Cancer, 31, 819, 10.1016/0959-8049(95)00124-2 Arvizo, 2013, Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle, Proc. Natl. Acad. Sci.U S A, 110, 6700, 10.1073/pnas.1214547110 Avigo, 2017, Enhanced photoacoustic signal of passion fruit-like nanoarchitectures in a biological environment, J. Phys. Chem. C., 121, 6955, 10.1021/acs.jpcc.6b11799 Cassano, 2017, Passion fruit-like nano-architectures: a general synthesis route, Sci. Rep., 7, 43795, 10.1038/srep43795 Cassano, 2019, Biosafety and biokinetics of noble metals: the impact of their chemical nature, ACS Appl. Bio Mater., 2, 4464, 10.1021/acsabm.9b00630 Cassano, 2018, Ultrasmall-in-Nano approach: enabling the translation of metal nanomaterials to clinics, Bioconjug. Chem., 29, 4, 10.1021/acs.bioconjchem.7b00664 Cassano, 2015, Biodegradable hollow silica nanospheres containing gold nanoparticle arrays, Chem. Commun., 51, 9939, 10.1039/C5CC02771C Cassano, 2016, Biodegradable passion fruit-like nano-architectures as carriers for cisplatin prodrug, Part. Part. Syst. Charact., 33, 818, 10.1002/ppsc.201600175 Cassano, 2019, Photothermal effect by NIR-responsive excretable ultrasmall-in-nano architectures, Mater. Horizons, 6, 531, 10.1039/C9MH00096H Cassano, 2019, Biodegradable ultrasmall-in-nano gold architectures: mid-period in vivo distribution and excretion assessment, Part. Part. Syst. Charact., 36, 1800464, 10.1002/ppsc.201800464 Chan, 2014, The wonderful colors of the hematoxylin–eosin stain in diagnostic surgical pathology, Int. J. Surg. Pathol., 22, 12, 10.1177/1066896913517939 Chau, 2016, Antiangiogenic agents in head and neck squamous cell carcinoma: tired of going solo, Cancer, 122, 3592, 10.1002/cncr.30352 Crespo, 2016, The chick embryo chorioallantoic membrane as an in vivo model to study metastasis, Bio Protocol., 6, 1, 10.21769/BioProtoc.1962 Curry, 2014, Tumor microenvironment in head and neck squamous cell carcinoma, Semin. Oncol., 41, 217, 10.1053/j.seminoncol.2014.03.003 Deryugina, 2008, Chapter 2 chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules, Methods Enzymol., 444, 21, 10.1016/S0076-6879(08)02802-4 El-Kenawi, 2013, Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales, Br. J. Pharmacol., 170, 712, 10.1111/bph.12344 El-Sayyad, 2009, Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats, Int. J. Biol. Sci., 5, 466, 10.7150/ijbs.5.466 Giannone, 2020, A cost-effective approach for non-persistent gold nano-architectures production, Nanomaterials, 10, 1600, 10.3390/nano10081600 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Hoebers, 2008, Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma, Head Neck, 30, 1216, 10.1002/hed.20865 Huysentruyt, 2010, Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer, Int. J. Cancer, 126, 65, 10.1002/ijc.24649 Isoda, 2013, Liver injury induced by thirty- and fifty-nanometer-diameter silica nanoparticles, Biol. Pharm. Bull., 36, 370, 10.1248/bpb.b12-00738 Jain, 2010, Delivering nanomedicine to solid tumors, Nat. Rev. Clin. Oncol., 7, 653, 10.1038/nrclinonc.2010.139 Kim, 2005, Repopulation of cancer cells during therapy: an important cause of treatment failure, Nat. Rev. Cancer, 5, 516, 10.1038/nrc1650 Kleibeuker, 2015, Examination of the role of galectins during in vivo angiogenesis using the chick chorioallantoic membrane assay, Methods Mol. Biol., 1207, 305, 10.1007/978-1-4939-1396-1_20 Krock, 2011, Hypoxia-induced angiogenesis: good and evil, Genes Cancer, 2, 1117, 10.1177/1947601911423654 Kunz, 2019, Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma, PLoS One, 14, e0215312, 10.1371/journal.pone.0215312 Lee, 2015, Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo, Neoplasia, 17, 190, 10.1016/j.neo.2014.12.008 Li, 2016, Expression of inhibitor of differentiation-1 and its effects on angiogenesis in gastric cancer, Cancer Biother. Radiopharm., 31, 233, 10.1089/cbr.2016.2043 Li, 2014, Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts, Int. J. Mol. Sci., 15, 19265, 10.3390/ijms151019265 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method, Methods, 25, 402, 10.1006/meth.2001.1262 Mapanao, 2021, Tumor grafted – chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation, Expert Opin. Drug Metab. Toxicol., 17, 947, 10.1080/17425255.2021.1879047 Mapanao, 2020, Biokinetics and clearance of inhaled gold ultrasmall-in-nano architectures, Nanoscale Adv., 2, 3815, 10.1039/D0NA00521E Mapanao, 2018, Endogenously triggerable ultrasmall-in-nano architectures: targeting assessment on 3D pancreatic carcinoma spheroids, ACS Omega, 3, 11796, 10.1021/acsomega.8b01719 Mapanao, 2021, Combined chemo-photothermal treatment of three-dimensional head and neck squamous cell carcinomas by gold nano-architectures, J. Colloid Interf. Sci., 582, 1003, 10.1016/j.jcis.2020.08.059 Mapanao, 2020, Three-dimensional tumor models: promoting breakthroughs in nanotheranostics translational research, Appl. Mater. Today, 19, 100552, 10.1016/j.apmt.2019.100552 Matta, 2009, Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma, Head Neck Oncol., 1, 6, 10.1186/1758-3284-1-6 McDermott, 2019, Epidemiology of head and neck squamous cell carcinomas: impact on staging and prevention strategies, Curr. Treat. Options Oncol., 20, 43, 10.1007/s11864-019-0650-5 Mineta, 2000, Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas, Br. J. Cancer, 83, 775, 10.1054/bjoc.2000.1357 Molinolo, 2009, Dysregulated molecular networks in head and neck carcinogenesis, Oral Oncol., 45, 324, 10.1016/j.oraloncology.2008.07.011 Mukherjee, 2005, Antiangiogenic properties of gold nanoparticles, Clin. Cancer Res., 11, 3530, 10.1158/1078-0432.CCR-04-2482 Muscella, 2016, Antitumour and antiangiogenic activities of [Pt( O , O′ -acac)(γ-acac)(DMS)] in a xenograft model of human renal cell carcinoma, Br. J. Pharmacol., 173, 2633, 10.1111/bph.13543 Muz, 2015, The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy, Hypoxia, 3, 83, 10.2147/HP.S93413 Nair, 2016, A simple practice guide for dose conversion between animals and human, J. Basic Clin. Pharm., 7, 27, 10.4103/0976-0105.177703 Norrby, 2006, In vivo models of angiogenesis Angiogenesis, J. Cell. Mol. Med., 10, 588, 10.1111/j.1582-4934.2006.tb00423.x Osman, 2014, Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience, Eur. Arch. Otorhinolaryngol., 271, 2253, 10.1007/s00405-013-2749-9 Peridis, 2011, Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis, Eur. Arch. Otorhinolaryngol., 268, 661, 10.1007/s00405-011-1488-z Pfeffer, 2018, Apoptosis: a target for anticancer therapy, Int. J. Mol. Sci., 19, 448, 10.3390/ijms19020448 Pillai, 2017, 453 Pozas, 2019, Targeting angiogenesis in pancreatic neuroendocrine tumors: resistance mechanisms, Int. J. Mol. Sci., 20, 4949, 10.3390/ijms20194949 Rao, 2015, Induction chemotherapy with cisplatin and 5-fluorouracil in advanced head and neck cancers: a short term response evaluation, J. Clin. Diagn. Res., 9, XC08 Robert, 2008, Recent advances in head and neck cancer reconstruction, N. Engl. J. Med., 47, 185 Romanowska, 2020, Head and neck squamous cell carcinoma: epigenetic landscape, Diagnostics, 11, 34, 10.3390/diagnostics11010034 Romesser, 2014, A prognostic volumetric threshold of gross tumor volume in head and neck cancer patients treated with radiotherapy, Am. J. Clin. Oncol., 37, 154, 10.1097/COC.0b013e31826e04d6 Rovithi, 2017, Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing, Sci. Rep., 7, 1, 10.1038/srep44686 Santi, 2020, Endogenously-activated ultrasmall-in-nano therapeutics: assessment on 3D head and neck squamous cell carcinomas, Cancers (Basel)., 12, 1063, 10.3390/cancers12051063 Sarogni, 2021, A standard protocol for the production and bioevaluation of ethical in vivo models of HPV-negative head and neck squamous cell carcinoma, ACS Pharmacol. Transl. Sci., 4, 1227, 10.1021/acsptsci.1c00083 Schneider-Stock, 2020, The CAM assay as an alternative in vivo model for drug testing, 303 Shabani, 2015, A review of chemotherapy for locally advanced head and neck cancers, Rep. Radiother. Oncol., 2, 10.5812/rro.2(1)2015.2261 Sharma, 2020, Comparative study of induction chemotherapy followed by concurrent weekly chemoradiotherapy vs 3-weekly chemoradiotherapy in locally advanced head and neck cancer, J. Med. Sci. Clin. Res., 08, 25, 10.4103/JCSR.JCSR_18_19 Shuryak, 2018, Dose dependence of accelerated repopulation in head and neck cancer: supporting evidence and clinical implications, Radiother. Oncol., 127, 20, 10.1016/j.radonc.2018.02.015 Smith, 2019 Sowa, 2017, Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression, Cancer Med., 6, 288, 10.1002/cam4.991 Sun, 2014, Engineered nanoparticles for drug delivery in cancer therapy, Angew. Chem. Int. Ed., 53, 12320, 10.1002/anie.201403036 Surucu, 2016, Decision trees predicting tumor shrinkage for head and neck cancer, Technol. Cancer Res. Treat., 15, 139, 10.1177/1533034615572638 Tamargo, 2015, Cancer chemotherapy and cardiac Arrhythmias: a review, Drug Saf., 38, 129, 10.1007/s40264-014-0258-4 Tong, 2008, Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF, J. Cell. Biochem., 105, 1202, 10.1002/jcb.21920 Törnqvist, 2014, Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing, PLoS One, 9, 1, 10.1371/journal.pone.0101638 van Kuijk, 2016, Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis, Front. Oncol., 6, 1, 10.3389/fonc.2016.00069 Vassilakopoulou, 2015, Targeting angiogenesis in head and neck cancer, Oral Oncol., 51, 409, 10.1016/j.oraloncology.2015.01.006 Vlamidis, 2018, Bringing again noble metal nanoparticles to the forefront of cancer therapy, Front. Bioeng. Biotechnol., 6, 143, 10.3389/fbioe.2018.00143 Withers, 1988, The hazard of accelerated tumor clonogen repopulation during radiotherapy, Acta Oncol.(Madr)., 27, 131, 10.3109/02841868809090333